Objective Capital’s David H. Crean to Serve as Guest Panelist at LaunchBio Event, November 14, 2017
San Diego, November 9, 2017 — Objective Capital Partners, a middle market M&A Advisory Firm located in Southern California, is pleased to announce that David H. Crean, Ph.D., one of its Managing Directors who heads its thriving life science and healthcare practice, has been invited to speak as a guest panelist at LaunchBio Series Event for life science companies entitled BIO Buck$ Fast Forward: A Start-ups Guide to Investment Banks. Dr. Crean will be joined by Charlie Adams, Cantor Fitzgerald and Tony Grover, VP of Business Development at Banyan Biomarker.
There are many options when raising capital for your startup – angel $$, VC’s, grants – but have you considered working with an investment bank? Join our panelists and learn about the various options for funding your life science startup. Panelists will discuss the specific ways investment banks can help entrepreneurs – as confidantes, relationship builders, analysts, and sources of capital. Moderator Lisa Walters, an investment banker-turned-entrepreneur, will shed light on the view from both sides of the deal.
The LaunchBio event will be held Tuesday, November 14, 2017 from 11:30 AM – 1:00 PM PST at GENESIS at Campus Point, 4242 Campus Point Court, San Diego, CA 92121. For more information, please visit https://www.eventbrite.com/e/fast-forward-a-startups-guide-to-investment-banks-tickets-38927783047.
About Objective Capital Partners
Objective Capital Partners is a leading M&A investment banking firm serving the transaction needs of middle market and growth stage companies in four industry sectors of expertise: Technology, Consumer, Healthcare & life sciences, and Business services. Headquartered in Southern California since 2006, the firm provides sell-side, buy-side, growth capital and valuation services. The executive team has collectively engaged in more than 500 successful transactions and bring a unique combination of investment banking, private equity, and business ownership experience that enables Objective Capital Partners to provide large enterprise caliber investment banking services to middle-market companies. Securities and investment banking services are offered through BA Securities, LLC Member FINRA, SIPC. Principals of Objective Capital are Registered Representatives of BA Securities. Objective Capital Partners and BA Securities are separate and unaffiliated entities. Additional information on Objective Capital Partners is available at www.objectivecp.com.
LaunchBio is a nonprofit organization that identifies, counsels, and supports high-growth, high-impact life science and biotechnology companies. Its mission is to build an ecosystem of innovation for the benefit of human health and well-being. LaunchBio’s impact is measured by its success in connecting entrepreneurs with knowledge, capital, and talent – including each other – not only within geographic regions but across the nation’s leading life science hubs. For more information on the organization, please visit https://launchbio.org/.
This news release is for informational purposes only and does not constitute an offer, invitation or recommendation to buy, sell, subscribe for or issue any securities. While the information provided herein is believed to be accurate and reliable, Objective Capital Partners and BA Securities, LLC makes no representations or warranties, expressed or implied, as to the accuracy or completeness of such information. All information contained herein is preliminary, limited and subject to completion, correction or amendment. It should not be construed as investment, legal, or tax advice and may not be reproduced or distributed to any person.
Contact: Mandy F. Woods
Business Office Manager